Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-01-23

Clinical Trial Update: Ergometrine Versus Oxytocin in the Management of Atonic Post-partum Haemorrhage (PPH) in Women Delivered Vaginally [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing ergometrine to oxytocin for the management of atonic postpartum hemorrhage in vaginal deliveries; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ergometrine (ergometrine)
  • Oxytocin (Oxytocin)

Snippet

Sponsor: Cairo University | Conditions: Post Partum Hemorrhage | Phase 3 | Status: UNKNOWN